Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 4/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.53 |
| ▸ | LMNA | P02545 | 1/20 | 0.38 |
| ▸ | SLC15A2 | Q16348 | 1/20 | 0.38 |
| ▸ | FFAR3 | O14843 | 1/20 | 0.38 |
| ▸ | LCK | P06239 | 1/20 | 0.38 |
| ▸ | FYN | P06241 | 1/20 | 0.38 |
| ▸ | GRIK1 | P39086 | 1/20 | 0.37 |
| ▸ | TP53 | P04637 | 1/20 | 0.37 |
| ▸ | TRPA1 | O75762 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.36 |
| ▸ | CHRM1 | P11229 | 1/20 | 0.35 |
| ▸ | AKR1A1 | P14550 | 1/20 | 0.35 |
| ▸ | CHRM3 | P20309 | 1/20 | 0.35 |
| ▸ | HTR2A | P28223 | 1/20 | 0.35 |
| ▸ | HTR2C | P28335 | 1/20 | 0.35 |
| ▸ | ADRA1A | P35348 | 1/20 | 0.35 |
| ▸ | HRH1 | P35367 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11309347 | 0.88 | TDP1 (0.48) | TDP1ALDH1A1LMNASLC15A2FFAR3 | |
| SCHEMBL27602519 | 0.83 | TDP1 (0.43) | TDP1ALDH1A1LMNASLC15A2GRIK1 | |
| SCHEMBL233057 | 0.80 | ALDH1A1 (0.53) | TDP1ALDH1A1LMNASLC15A2TRPA1 | |
| SCHEMBL10455829 | 0.79 | ALDH1A1 (0.40) | TDP1ALDH1A1GRIK1 | |
| SCHEMBL17637932 | 0.78 | TDP1 (0.58) | TDP1ALDH1A1LMNASLC15A2FFAR3 | |
| SCHEMBL15455713 | 0.78 | ALDH1A1 (0.50) | TDP1ALDH1A1LMNASLC15A2TRPA1 | |
| SCHEMBL8519589 | 0.78 | TDP1 (0.50) | TDP1ALDH1A1LMNASLC15A2GRIK1 | |
| SCHEMBL4342888 | 0.78 | ALDH1A1 (0.50) | TDP1ALDH1A1LMNASLC15A2TRPA1 | |
| SCHEMBL9569276 | 0.77 | ALDH1A1 (0.39) | TDP1ALDH1A1 | |
| SCHEMBL6523715 | 0.77 | ALDH1A1 (0.39) | TDP1ALDH1A1GRIK1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 28 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2473152-B1 | COMPOSITION COMPRISING A HYDROPHOBIC DYE, A SPECIFIC MINERAL AND/OR ORGANIC ALKALINE AGENT, A SPECIFIC COMPOUND (I) AND A SPECIFIC ORGANIC COMPOUND (II), AND USE THEREOF IN DYEING | OREAL (FR) | 2020-03-18 | — | — | EP | claimed |
| CN-102596156-A | Composition comprising a hydrophobic dye, a specific mineral and/or organic alkaline agent, a specific compound (i) and a specific organic compound (ii), and use thereof in dyeing | OREAL | 2012-07-18 | — | — | CN | claimed |
| EP-0367132-B1 | Light-sensitive composition | BASF AG (DE) | 1997-04-02 | — | — | EP | claimed |
| US-20230398226-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS | CIDARA THERAPEUTICS, INC. | 2023-12-14 | — | — | US | disclosed |
| US-11833213-B2 | Compositions and methods for the treatment of viral infections | CIDARA THERAPEUTICS, INC. (US) | 2023-12-05 | — | — | US | disclosed |
| US-20230190950-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS | CIDARA THERAPEUTICS, INC. | 2023-06-22 | — | — | US | disclosed |
| EP-2473152-B1 | COMPOSITION COMPRISING A HYDROPHOBIC DYE, A SPECIFIC MINERAL AND/OR ORGANIC ALKALINE AGENT, A SPECIFIC COMPOUND (I) AND A SPECIFIC ORGANIC COMPOUND (II), AND USE THEREOF IN DYEING | OREAL (FR) | 2020-03-18 | — | — | EP | disclosed |
| CN-109890796-A | Weeding pyridazinone compound | 先正达参股股份有限公司 | 2019-06-14 | — | — | CN | disclosed |
| CN-103980103-B | PHENOLIC COMPOUND, EPOXY RESIN, EPOXY RESIN COMPOSITION, PREPREG, AND CURED PRODUCT THEREOF | 日本化药株式会社 | 2017-04-12 | — | — | CN | disclosed |
| CN-103764653-B | As compound and the composition of c-Kit kinase inhibitor | IRM LLC (BM) | 2015-12-02 | — | — | CN | disclosed |
| US-20150147309-A1 | ALLOSTERIC CHAPERONES AND USES THEREOF | CONSIGLIO NAZIONALE DELLE RICERCHE (IT) | 2015-05-28 | — | — | US | disclosed |
| US-20120004442-A1 | SYNTHESIS OF (PHENYLALKYLOXY)PHENYL-OXOBUTANOIC ACIDS | WELLSTAT THERAPEUTICS CORPORATION (US) | 2012-01-05 | — | — | US | disclosed |
| WO-2011075498-A1 | ONE-COMPONENT, AMBIENT CURABLE WATERBORNE COATING COMPOSITIONS, RELATED METHODS AND COATED SUBSTRATES | PPG INDUSTRIES OHIO, INC. (US) | 2011-06-23 | — | — | WO | disclosed |
| US-20110151128-A1 | ONE-COMPONENT, AMBIENT CURABLE WATERBORNE COATING COMPOSITIONS, RELATED METHODS AND COATED SUBSTRATES | PPG INDUSTRIES OHIO, INC. (US) | 2011-06-23 | — | — | US | disclosed |
| US-20100160392-A1 | HISTONE DEACETYLASE INHIBITORS | QUEEN MARY & WESTFIELD COLLEGE (GB) | 2010-06-24 | — | — | US | disclosed |
| WO-2010053910-A1 | SYNTHESIS OF (PHENYLALKYLOXY)PHENYL-OXOBUTANOIC ACIDS | WELLSTAT THERAPEUTICS CORPORATION (US) | 2010-05-14 | — | — | WO | disclosed |
| US-20090309060-A1 | Additives for Electrolyte Solution and Electrolyte Solution | OTSUKA CHEMICAL CO., LTD. (JP) | 2009-12-17 | — | — | US | disclosed |
| CN-101479818-A | Additive for electrolyte and electrolyte | OTSUKA CHEMICAL CO LTD (JP) | 2009-07-08 | — | — | CN | disclosed |
| US-4244690-A | USING AN AQUEOUS ALKALI SOLUTION OF THIOUREA DIOXIDE IN THE PRESENCE OF A KETONE COMPOUND | TOKAI DENKA KOGYO KABUSHIKI KAISHA (JP) | 1981-01-13 | — | — | US | disclosed |
| US-3988468-A | 7-Methoxy-6-thiatetracyclines and their preparation | MERCK PATENT GESELLSCHAFT MIT BESCHRANKTER HAFTUNG (DT) | 1976-10-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (7 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230398226-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF VIRAL INFECTIONS | FCGR3B, ALB, FCGR1A | TDP1 4479/4885ALDH1A1 3164/4885LMNA 3451/4885 |
| US-20120004442-A1 | SYNTHESIS OF (PHENYLALKYLOXY)PHENYL-OXOBUTANOIC ACIDS | PGD, HPD, MLYCD | TDP1 3194/4885ALDH1A1 346/4885LMNA 2006/4885 |
| US-20090309060-A1 | Additives for Electrolyte Solution and Electrolyte Solution | SLC9A1, SLC26A3, AQP1 | TDP1 2723/4885ALDH1A1 342/4885LMNA 568/4885 |
| US-20230190950-A1 | COMPOSITIONS AND METHODS FOR THE TREATMENT OF BACTERIAL INFECTIONS | FCGR3B, FCGR1A, FCGR2A | TDP1 4714/4885ALDH1A1 4869/4885LMNA 3986/4885 |
| US-11833213-B2 | Compositions and methods for the treatment of viral infections | FCGR3B, ALB, FCGR1A | TDP1 4479/4885ALDH1A1 3164/4885LMNA 3451/4885 |
| US-20100160392-A1 | HISTONE DEACETYLASE INHIBITORS | HDAC3, HDAC1, HDAC4 | TDP1 3241/4885ALDH1A1 2757/4885LMNA 2226/4885 |
| US-20150147309-A1 | ALLOSTERIC CHAPERONES AND USES THEREOF | GAA, GBA3, GBA1 | TDP1 1118/4885ALDH1A1 3294/4885LMNA 3142/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.